NX-019

N/A

Report date: 2026/05/08 20:02:52
NME

Base Information

Drug NameNX-019
Drug Alias NameNX-019
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEGFR 19del inhibitorsEGFR T790M inhibitorsEGFR L858R inhibitors +[5] 
TargetsEpidermal growth factor receptor erbB1EGFR 19delEGFR T790M +[5] 
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesTaiwanSouth Korea
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesNalo Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesNalo Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A